Skip to main content
Home

Mark Cuban, Humana CEO announce drug pricing partnership during Forbes panel

Humana

Mark Cuban's startup Cost Plus Drugs and insurer Humana are said to be working on a deal that would allow Medicare Advantage patients to buy drugs directly from manufacturers. The terms of the agreement—which Forbes reports is in its early stages—are still unknown.

  • Read more about Mark Cuban, Humana CEO announce drug pricing partnership during Forbes panel

Neuralink users reveal power to move robotic arms, play video games with their minds

Elonk Musk Neuralink

Elon Musk showing off the Neuralink in 2019. Photo by Steve Jurvetson. 

Source

Wikipedia

The results were shown in multiple posts on X. A clinical trial to prove the safety and efficacy of Elon Musk's brain implant is ongoing, with 12 people currently using the devices.

  • Read more about Neuralink users reveal power to move robotic arms, play video games with their minds

TAVR still a safe treatment option for immunocompromised patients

Doctor patient

While patients with a weakened immune system are still more likely to die after TAVR than other patients, those deaths are largely not related to the procedure or any other cardiovascular issues. This new meta-analysis explored data from a variety of clinical trials.

  • Read more about TAVR still a safe treatment option for immunocompromised patients

Pope welcomes cardiologists to Vatican City

Pope Leo XIV interventional cardiology

Image courtesy of Vatican News/Vatican Media. 

Pope Leo XIV told interventional cardiologists their work “stands at the crossroads of science, compassion and ethical responsibility.” When they treat patients, he added, they are treating the heart “both physically and metaphorically, bringing relief to those who suffer.” 

  • Read more about Pope welcomes cardiologists to Vatican City

Most organizations using AI for radiology are unsure of its ROI

radiologist radiology pay compensation money dollar

New survey data suggest that AI reimbursement is still lagging. However, leaders remain confident in the technology's long-term impact.

  • Read more about Most organizations using AI for radiology are unsure of its ROI

Edwards Lifesciences shares positive outlook for 2026, pointing to continued importance of TAVR

Edwards Lifesciences Sapien 3 TAVR valves at TCT 2024 DF 1

Sapien 3 TAVR valves on display at TCT 2024.

The company expects TAVR sales alone to be as high as $4.9 billion in 2026. Other minimally invasive therapies are projected to make a major impact as well.

  • Read more about Edwards Lifesciences shares positive outlook for 2026, pointing to continued importance of TAVR

FDA commissioner claims Biden administration hid heart risks of COVID-19 vaccines from public

artificial intelligence ai in healthcare

The allegation came days after an internal FDA memo linked the vaccines to the deaths of multiple children. A group of former FDA commissioners pushed back against the content of that memo.

  • Read more about FDA commissioner claims Biden administration hid heart risks of COVID-19 vaccines from public

Kaiser Permanente agrees to $46M settlement over data incident affecting 13.4M people

the-kaiser-permanente-thrive-center-street-telegraph_1300x867.jpg

Kaiser Permanente Thrive Center.

The managed care company does not admit to doing anything wrong. The data breach constituted its use of third-party tracking technology on its website, which shared data with Google, Microsoft, Twitter, Meta and others.

  • Read more about Kaiser Permanente agrees to $46M settlement over data incident affecting 13.4M people

Judge dismisses radiologist’s fraud claims stemming from $20M sale to private equity

judge court gavel justice system legal

Gregory R. Ball, MD, of Orchard Park, New York, and his attorneys first filed the complaint against Southtowns Radiology Associates in February, seeking some $2 million in damages. 

  • Read more about Judge dismisses radiologist’s fraud claims stemming from $20M sale to private equity

Radiology vendor Agfa to eliminate 145 positions amid continued declines in film business

Pascal Juéry CEO Agfa-Gevaert

Pascal Juéry, CEO of the Agfa-Gevaert Group

Source

Flint Group

The move is part of over $29 million (USD) in cost reductions, revealed last month during the Belgium-based company's quarterly earnings announcement. 

  • Read more about Radiology vendor Agfa to eliminate 145 positions amid continued declines in film business

Pagination

    • First page « First
    • Previous page ‹ Previous
    • Page …126
    • Page 127
    • Page 128
    • Page 129
    • Current page 130
    • Page 131
    • Page 132
    • Page 133
    • Page 134 …
    • Next page Next ›
    • Last page Last »
Subscribe
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
 
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
 
Design by Adaptive Theme